Stock Events

Stock Events

Search...

Galmed Pharmaceuticals (GLMD) Q1 2024 Earnings

4AprConfirmed

Q1 2023

Q2 2023

Q3 2023

Q1 2024

-1.5

-1.08

-0.66

-0.24

Details

Expected EPS

-0.32

Actual EPS

-0.98

Surprise EPS

-0.66

Surprise Percent

+206.25%

Description

Galmed Pharmaceuticals (GLMD) has reported earnings of -0.98 per share for Q1 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.